מיכשור לטיפולים בבתי חולים
The IPV-2C
The IPV-2C enhances the clinical versatility of IPV therapy by providing added control, including demand CPAP to reduce work-of-breathing (WOB) while transitioning to Flow Ventilation, as well as independent CPAP for weaning.
Designed specifically for hospital use and with the versatility to treat most patients, including those in the NICU, the IPV-2C provides Lung Conditioning Therapy, either invasively or noninvasively, for patients in all hospital units. Flow Ventilation enables improved clearance of secretions while supporting lung recruitment and gas exchange. The Phasitron provides a lung protective strategy and also makes the IPV-2C compatible with conventional ventilators, preventing the need to switch between different devices. It also provides an added advantage of demand CPAP to reduce WOB while transitioning to Flow Ventilation, as well as independent CPAP for weaning.
Patients who may benefit include those with the following conditions:
- COPD
- Asthma
- Atelectasis
- Pneumonia
- Premature Lungs
- Bronchitis
Pulmonary complications of:
- Cystic Fibrosis
- Alpha-1
- SMA
- ALS
Benefits:
- Restores FRC
- Reduces time in the ICU
- Reduces oxygen need at discharge from NICU
- Improves Oxygenation and reduces PaCO2
- Provides better management of COPD exacerbations
- Reduces nosocomial infection
- Improves airway clearance
- Lung recruitment by treating atelectasis
- Demand CPAP
Features:
- Portable
- Lightweight
- Additional control sensitivity
- Pneumatically powered by hospital air or O2
- Compatible with most conventional ventilators
- Demand CPAP
- Independent CPAP
- Often used with Phasitron Kit A50095-D
the IPV-1
The new IPV-1 is a new version of the IPV-1C with one big change, we can work with oxygen or medical air, and ezey one connection with a phasitron P5-UC
versatile Flow Ventilation® solution built to provide lung conditioning therapy, which assists in the restoration of Functional Residual Capacity (FRC) by providing ventilation and airway clearance for most patient population
Designed specifically for hospital use, the IPV-1C is a Flow Ventilation device that is safe and provides Lung Conditioning Therapy for a wide range of patients. Flow Ventilation enables improved clearance of secretions while supporting lung recruitment and gas exchange. The Phasitron kit provides a lung protective strategy, and also makes the IPV-1C compatible with conventional ventilators, preventing the need to switch between different devices.
The benefits of the IPV-1C are safely available to patients of all ages.
Patients who may benefit include those with the following conditions:
- COPD
- Asthma
- Atelectasis
- Pneumonia
- Premature Lungs
- Bronchitis
Pulmonary complications of:
- Cystic Fibrosis
- Alpha-1
- SMA
- ALS
Libera
The Libera is a highly advanced technological, cough assist and much more.
delivering substantial benefits to both the medical staff and patients.
as outlined below:
Cough Assist+
From conventional mechanical in-exsufflation with positive and negative pressures, to the most advanced controls for an optimal tailor-made therapy.
EFA®
Improves expiratory flow to aid secretion transport to the upper airways, making clearance easier—even for patients with impaired cough or low compliance.
Cough Trial
Enables assessment of cough effectiveness by providing objective data that supports personalized therapy and tracks clinical progress.
Continuous Positive Pressure / PulsePositive
pressure delivered throughout the
entire respiratory cycle enhances
ventilation by promoting lung
recruitment and facilitating secretion
clearance.
IPPB
Supports lung re-expansion and helps prevent respiratory issues in hypoventilating andpost-operative patients through targeted positive pressure ventilation.
The IPV-1C
Pulmonary complications of:
- Cystic Fibrosis
- Alpha-1
- SMA
- ALS
The IPV-1C is a versatile Flow Ventilation® solution built to provide lung conditioning therapy, which assists in the restoration of Functional Residual Capacity (FRC) by providing ventilation and airway clearance for most patient population
Designed specifically for hospital use, the IPV-1C is a Flow Ventilation device that is safe and provides Lung Conditioning Therapy for a wide range of patients. Flow Ventilation enables improved clearance of secretions while supporting lung recruitment and gas exchange. The Phasitron kit provides a lung protective strategy, and also makes the IPV-1C compatible with conventional ventilators, preventing the need to switch between different devices.
The benefits of the IPV-1C are safely available to patients of all ages.
Patients who may benefit include those with the following conditions:
- COPD
- Asthma
- Atelectasis
- Pneumonia
- Premature Lungs
- Bronchitis
Benefits:
- Restores FRC
- Reduces time in the ICU
- Improves Oxygenation and reduces PaCO2
- Provides better management of COPD exacerbations
- Reduces nosocomial infection
- Improves airway clearance
- Lung recruitment by treating atelectasis
Features:
- Portable
- Lightweight
- Pneumatically powered by hospital air or O2
- Compatible with most conventional ventilators